Table 2. Non-malignant complications developing in the AIP and IgG4-SC cohort.
Non-malignant complications | % Of 115 patients |
---|---|
Liver | |
Cirrhosis and liver failure | 5 |
Liver transplant | 0.9 |
Pancreas | |
Exocrine insufficiency | 53 |
Endocrine insufficiency (diabetes) | 37 |
Renal | |
Impaired renal function—stage 2–4 CKD | 12 |
Vascular | |
Portal and splenic vein thrombosis | 9 |
AIP, autoimmune pancreatitis; CKD, chronic kidney disease; IgG4-SC, IgG4-related sclerosing cholangitis.